$61.80—Stale · unknown old
NYSE • Last print unknown ago
$61.80—Stale · unknown old
9/27/26
Centene (CNC)
Sunday
10:21 PM
ThesisRecent strategic acquisitions and improved operational metrics have shifted investor sentiment positively, indicating a potential turnaround in Centene's financial performance.
Revenue Outlook
What’s Driving the Stock
- 01Centene's recent acquisition of a regional Medicaid provider is expected to increase its member base by 15% and enhance its market share in key states.
- 02The company's medical loss ratio has improved to 85%, indicating better cost management and efficiency in care delivery.
- 03Centene's expansion into telehealth services has resulted in a 30% increase in member engagement, potentially driving higher retention rates.
- 04Recent legislative changes have increased funding for Medicaid programs, which could enhance Centene's revenue growth prospects in the coming quarters.
- 05Increased focus on value-based care
- 06Expansion of telehealth services
- 07Changes in Medicaid enrollment levels due to state policy adjustments
- 08Regulatory changes impacting reimbursement rates
FY2025 Snapshot
- Revenue
- $194.8B
- Rev. Growth
- +19.4%
- Gross Margin
- 12.2%
- Op. Margin
- -3.9%
- Net Margin
- -3.4%
- Net Income
- $-6.7B
- NI Growth
- -302%
- EPS
- $-13.61
- 1Y Return
- +78.4%
CNC Chart
My Notes
- "Management emphasized, 'Our strategic initiatives are positioning us for sustainable growth and improved member outcomes.'"
- Moat: Centene's competitive advantage lies in its established relationships with state governments and its scale in Medicaid services…
- value - Centene's low price-to-sales ratio and strong cash flow yield attract value investors looking for turnaround potential.
- Interest rates affect Centene indirectly through the cost of capital for potential acquisitions and the overall economic environment…
- Watch on earnings: Medicaid enrollment numbers, Medical loss ratio (MLR), Operating cash flow.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $196.2B to $193.0B as centene's recent acquisition of a regional medicaid provider is expected to increase its member base by 15% and enhance.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers